Israel vs Marshall Islands: The number of people with susceptibility test result for rifampicin
Israel
100
in 2021
Marshall Islands
100
in 2021
Israel rank
2nd
Marshall Islands rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Israel
- Marshall Islands
How they compare
Israel currently reports 100 against 100 in Marshall Islands, a difference of 0.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Marshall Islands ahead.
Israel ranks 2nd and Marshall Islands ranks 2nd of 146 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Israel | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.2 | 96.97 | 1.23 | Israel |
| 2020s | 100 | 87.04 | 12.96 | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Israel or Marshall Islands?
- Israel, at 100 against 100 in Marshall Islands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Israel and Marshall Islands?
- 0, with Israel ahead.
- How many years of comparable data are there for Israel and Marshall Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Israel and Marshall Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Israel ranks 2nd and Marshall Islands ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.